Physician profile
John M Delgaudio
NPI 1104937861
$48,986.05
in general payments reported to CMS, 2019-2025
10 companies · $881 in 2025
The $881 reported for 2025 was more than what a typical Otolaryngic Allergy provider received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,217 · 2020: $27K · 2021: $6,983 · 2022: $1,710 · 2023: $584 · 2024: $3,304 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $1,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $1,769.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $32,819.06 | 2019-2020 | |
| Medtronic, INC. | $12,090.74 | 2021-2025 | Propel, Stealthstation S8 Platform, Straightshot |
| Stryker Corporation | $2,254.84 | 2019-2025 | Audion Et Dilation System, Scopis Ent, Xpress Ent Dilation System |
| Regeneron Healthcare Solutions, INC. | $682.60 | 2022-2024 | Dupixent |
| Intersect Ent, INC. | $359.54 | 2019-2020 | |
| Spirair, INC. | $284.95 | 2025 | |
| Arrinex, INC. | $159.73 | 2019 | |
| Genzyme Corporation | $150.42 | 2022 | |
| Neurent Medical Limited | $99.16 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Karl Storz Endoscopy-America | $85.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Delgaudio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.